Skip to main content
NATURECELL CO.,LTD. logo

NATURECELL CO.,LTD. — Investor Relations & Filings

Ticker · 007390 ISIN · KR7007390008 KO Manufacturing
Filings indexed 273 across all filing types
Latest filing 2023-07-25 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 007390

About NATURECELL CO.,LTD.

http://en.naturecell.co.kr/

NATURECELL CO.,LTD. is a diversified company operating across the food, beverage, cosmetics, and biotechnology sectors. The company manufactures and sells a range of products including canned goods, health functional foods, and fruit juices. In addition to its consumer goods, NATURECELL has a significant focus on its high-tech biotechnology division, which is dedicated to stem cell research and development. This division conducts clinical trials for potential therapeutic applications, with a noted emphasis on treatments for degenerative diseases such as Alzheimer's.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Naturecell regarding an amendment to a previously filed 'Stock Option Grant Report' (주식매수선택권 부여에 관한 신고). It details changes to the number of recipients and the total number of shares granted due to cancellations. Since this is a specific regulatory disclosure regarding share-based compensation and capital structure changes (stock options), and it does not fit into the specific categories of 'Director's Dealing' or 'Share Issue', it is classified as a general Regulatory Filing (RNS).
2023-07-25 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees, including the number of shares, exercise price, and vesting conditions. Since this relates to the issuance of new rights/shares and capital structure changes, it falls under the category of Share Issue/Capital Change.
2023-07-25 Korean
[기재정정]기타주요경영사항(판매계약체결)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from NatureCell regarding a 'Correction Report' (정정신고) for a 'Major Management Matter' (기타 주요경영사항). It details a change in the status of a sales contract for a medical product (Jointstem) following a regulatory decision by the Ministry of Food and Drug Safety. Since this is a specific regulatory disclosure regarding business operations and contract status that does not fit into categories like financial reports, dividends, or M&A, it falls under the general regulatory filing category.
2023-07-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (often referred to as a 'Section 16' equivalent in the US) where company insiders report changes in their shareholdings. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions by company directors and executives.
2023-06-30 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) filing from Nature Cell. It details the completion of a third-party capital increase (유상증자), including the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-06-29 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from Naturecell, specifically regarding a 'Decision on Paid-in Capital Increase' (유상증자결정). It is a formal regulatory filing detailing the amendment of terms for a third-party capital increase, including payment dates, share issuance dates, and lock-up periods. Since this document details a change in capital structure and share issuance, it falls under the 'Share Issue/Capital Change' category.
2023-06-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.